Literature DB >> 34358807

How Common is Recent Denial of Suicidal Ideation among Ideators, Attempters, and Suicide Decedents? A Literature Review.

Joseph H Obegi1.   

Abstract

OBJECTIVE: It is sometimes stated that most people who die by suicide deny suicidal thoughts before their deaths. This narrative review examines the empirical basis for this assertion.
METHODS: Studies from 2000 to 2021 that examined the prevalence of the denial of suicidal thoughts among ideators in general, denial before suicide, and denial before and immediately after a suicide attempt were reviewed. Twenty-two papers met the inclusion criteria.
RESULTS: About 50% of ideators denied suicidal ideation (SI) during interviews. In addition, about half of decedents denied SI in the previous week or month before suicide, whereas about 30% denied SI in the previous week or month before a suicide attempt.
CONCLUSIONS: The denial of SI among ideators, attempters, and suicide decedents is an alarmingly common occurrence. Findings support the clinical wisdom that denial of SI is, by itself, an inadequate indicator of suicide risk.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Concealment; Denial; Nondisclosure; Suicidal ideation; Suicide

Mesh:

Year:  2021        PMID: 34358807     DOI: 10.1016/j.genhosppsych.2021.07.009

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  2 in total

1.  Integration of Face-to-Face Screening With Real-time Machine Learning to Predict Risk of Suicide Among Adults.

Authors:  Drew Wilimitis; Robert W Turer; Michael Ripperger; Allison B McCoy; Sarah H Sperry; Elliot M Fielstein; Troy Kurz; Colin G Walsh
Journal:  JAMA Netw Open       Date:  2022-05-02

Review 2.  Practical Advice for Primary Care Clinicians on the Safe and Effective Use of Vortioxetine for Patients with Major Depressive Disorder (MDD).

Authors:  C Brendan Montano; W Clay Jackson; Denise Vanacore; Richard H Weisler
Journal:  Neuropsychiatr Dis Treat       Date:  2022-04-12       Impact factor: 2.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.